Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2

Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2

(2022) Hongjie Xia et al.   Cell Host & Microbe

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission

(2022) Alba Escalera et al.   Cell Host & Microbe

Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

(2022) Constanze Kuhlmann et al.   LANCET

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

(2022) Delphine Planas et al.   NATURE

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

(2022) Peter J. Halfmann et al.   NATURE

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

(2022) Kang Wang et al.   NATURE

Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron

(2022) Jinyan Liu et al.   NATURE

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

(2022) Eddy Pérez-Then et al.   NATURE MEDICINE

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody

(2022) Wanchao Yin et al.   SCIENCE

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

(2022) John P. Evans et al.   Science Translational Medicine

Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern

(2022) Shan Su et al.   TRENDS IN IMMUNOLOGY

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection

(2022) Jing Zou et al.   Nature Communications

Cryo-EM structure of the SARS-CoV-2 Omicron spike

(2022) Gabriele Cerutti et al.   Cell Reports

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies

(2022) Xun Wang et al.   Emerging Microbes & Infections

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

(2022) Jingyou Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa

(2022) Juliet R. C. Pulliam et al.   SCIENCE

Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain

(2022) Gang Ye et al.   Nature Communications

A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity

(2021) Vincent Legros et al.   Cellular & Molecular Immunology

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera

(2021) Daming Zhou et al.   CELL

Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

(2021) Nicole L. Washington et al.   CELL

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

(2021) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

(2021) Frauke Muecksch et al.   IMMUNITY

SARS-CoV-2 variants of concern are emerging in India

(2021) Jasdeep Singh et al.   NATURE MEDICINE

Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021

(2021) Heather M. Scobie et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

(2021) Markus Hoffmann et al.   CELL

Mutational and phylogenetic analyses of the two lineages of the Omicron variant

(2021) Swagata Majumdar et al.   JOURNAL OF MEDICAL VIROLOGY

Sequence analysis of the emerging SARS‐CoV‐2 variant Omicron in South Africa

(2021) Lulan Wang et al.   JOURNAL OF MEDICAL VIROLOGY

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

(2021) Salim S Abdool Karim et al.   LANCET

Plasma Neutralization of the SARS-CoV-2 Omicron Variant

(2021) Fabian Schmidt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

(2021) Cong Zeng et al.   mBio

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients

(2021) Cong Zeng et al.   Cell and Bioscience

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

(2021) Li Zhang et al.   Emerging Microbes & Infections

SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia

(2020) Wei Chen et al.   BIOMEDICINE & PHARMACOTHERAPY

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

(2020) Leonid Yurkovetskiy et al.   CELL

Spike mutation D614G alters SARS-CoV-2 fitness

(2020) Jessica A. Plante et al.   NATURE

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors

(2020) Cong Zeng et al.   JCI Insight

Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-Cell Infection with New Replication Dependent Vectors

(2010) Dmitriy Mazurov et al.   PLoS Pathogens

Cell-free metabolic engineering promotes high-level production of bioactive Gaussia princeps luciferase

(2008) Aaron R. Goerke et al.   METABOLIC ENGINEERING